EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Rhea-AI Summary

EDAP TMS SA (Nasdaq: EDAP), a leader in robotic energy-based therapies, announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. The event is scheduled for September 9-11, 2024, in New York City. Ryan Rhodes, EDAP's CEO, will engage in a fireside chat and conduct one-on-one investor meetings.

Key details:

• Date: Tuesday, September 10th, 2024
• Time: 3:00-3:30 PM ET
• Location: Lotte New York Palace Hotel

A live webcast of the presentation will be available, with an archived version accessible in the Investors section of EDAP's website. This participation offers EDAP an opportunity to showcase its innovations and engage with potential investors.

        

LYON, France, August 29, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer, is scheduled to participate in a fireside chat and host 1x1 investor meetings at the H.C. Wainwright 26^th Annual Global Investment Conference, which is being held September 9-11, 2024, in New York City.

Date:             Tuesday, September 10^th

Time:             3:00-3:30 PM ET

Location:         Lotte New York Palace Hotel

Webcast:         https://journey.ct.events/view/e6563ee2-f715-420c-b29f-ccf7202cc9bd

The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website here.

About EDAP TMS SA
A recognized leader in the global therapeutic ultrasound market, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One^® in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith^® i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visit http://www.edap-tms.com, us.hifu-prostate.com and www.focalone.com.

Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com

Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com

FAQ

When is EDAP participating in the H.C. Wainwright Global Investment Conference?

EDAP is participating in the H.C. Wainwright 26th Annual Global Investment Conference on Tuesday, September 10th, 2024, from 3:00-3:30 PM ET.

Who will represent EDAP at the H.C. Wainwright conference?

Ryan Rhodes, the Chief Executive Officer of EDAP, will represent the company at the conference, participating in a fireside chat and hosting one-on-one investor meetings.

Where can investors watch EDAP's presentation at the H.C. Wainwright conference?

Investors can watch EDAP's presentation via a live webcast, accessible through the link provided in the press release. An archived version will also be available in the Investors section of EDAP's website.

What is the location of the H.C. Wainwright conference where EDAP is presenting?

The H.C. Wainwright 26th Annual Global Investment Conference is being held at the Lotte New York Palace Hotel in New York City.

What is EDAP's stock symbol?

EDAP's stock symbol is EDAP, and it is listed on the Nasdaq stock exchange.